Our Products
All designed to improve lives quality.
eKardio
Mavacamten is a novel, first-in-class oral medication approved as an allosteric modulator of cardiac myosin ATPase to treat obstructive hypertrophic cardiomyopathy (HCM) in patients. This medication is currently indicated for treating adults with symptomatic heart failure classified as New York Heart Association (NYHA) class II and III secondary to obstructive HCM and is aimed to improve functional capacity and alleviate symptoms.
Xelivex
Resmetirom is a thyroid hormone receptor-beta (THR-beta) agonist indicated in conjunction with diet and exercise for the treatment of adults with noncirrhotic nonalcoholic steatohepatitis (MASH) with moderate to advanced liver fibrosis (consistent with stages F2 to F3 fibrosis).
Pitolix
Pitolisant is used to treat cataplexy (weak or paralyzed muscles) or excessive daytime sleepiness (EDS) in patients with narcolepsy. Narcolepsy is an uncontrollable desire for sleep or a sudden attack of deep sleep.